ERFO — Laboratorio Farmaceutico Erfo SpA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
€10.47m
Enterprise Value
€10.48m
Revenue
€5.83m

Annual balance sheet for Laboratorio Farmaceutico Erfo SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1.23	0.369	1.47	0.843	0.376
Net Total Accounts Receivable
Net Total Receivables	0.713	0.818	2.46	1.22	0.858
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2.61	1.87	5.05	3.33	2.24
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.17	2.07	2.19	2.15	1.91
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	7.39	7.13	10.5	10.1	9.27
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.919	1.66	2.06	1.71	1.19
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	1.66	2.39	2.7	2.29	1.72
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5.72	4.74	7.83	7.86	7.55
Total Liabilities & Shareholders' Equity	7.39	7.13	10.5	10.1	9.27
Total Common Shares Outstanding